ViiV says early-stage data on VH184 for HIV could support twice-yearly dosing
ViiV Healthcare (GSK) said that phase 1 data on third-generation integrase strand transfer inhibitor VH184 indicates that...
Tag: PFE
15 states sue Trump administration over changes to U.S. vaccine schedule
15 states, mostly led by Democrats, are suing the Trump administration, seeking judicial intervention to reverse recent...
Pfizer wins full FDA approval for Braftovi in colorectal cancer
The U.S. FDA on Tuesday granted traditional approval for a first-line combination regimen involving Braftovi, an oral cancer...
CDC vaccine panel to meet in March after delay
The Centers for Disease Control and Prevention ((CDC)) has assigned Mar. 18–19 as the dates for the next meeting of its...
Pfizer strikes $495M deal for obesity drug rights in China
"Through this strategic collaboration with Pfizer China, we look forward to fully integrating Sciwind Biosciences'...
CDC Deputy Director Ralph Abraham steps down
Ralph Abraham, the principal deputy director of the Centers for Disease Control and Prevention, has left that position,...
Moderna sued for violating patent linked to Pfizer/ BioNTech COVID-19 shot
Moderna (MRNA) faces a lawsuit in the U.S. for allegedly infringing patent rights related to the COVID-19 shot developed by...
Pfizer says cancer therapy Braftovi improved survival in late-stage trial
Pfizer (PFE) announced on Tuesday that its colorectal cancer therapy, Braftovi, as part of a combination regimen, improved...
Changes to U.S. vaccine policy under RFK Jr. challenged in court
Several leading medical groups in the U.S. urged a federal judge on Friday to bar the CDC from holding its next vaccine...
Earnings Scorecard: 22 out of 23 healthcare firms deliver EPS wins this week
Twenty-three companies in the healthcare sector reported their earnings in the week ended February 6, bringing the...